Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-192508
Filing Date
2014-05-09
Accepted
2014-05-09 16:23:53
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d709582d10q.htm 10-Q 546938
2 EX-31.1 d709582dex311.htm EX-31.1 7766
3 EX-31.2 d709582dex312.htm EX-31.2 7763
4 EX-32.1 d709582dex321.htm EX-32.1 5398
  Complete submission text file 0001193125-14-192508.txt   3274554

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glyc-20140331.xml EX-101.INS 344216
6 XBRL TAXONOMY EXTENSION SCHEMA glyc-20140331.xsd EX-101.SCH 30326
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glyc-20140331_cal.xml EX-101.CAL 35527
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glyc-20140331_def.xml EX-101.DEF 141263
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20140331_lab.xml EX-101.LAB 280198
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20140331_pre.xml EX-101.PRE 197181
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 14829388
SIC: 2834 Pharmaceutical Preparations